title: Avalanche of direct-to-consumer drug marketing brings new questions.
authors.forename: L
authors.initials: L
authors.lastname: Newman
mesh_terms: D001007:Anxiety / Q000209:etiology*; D003257:Consumer Product Safety; D004345:Drug Industry / Q000592:standards*; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use; D005189:False Positive Reactions; D005221:Fatigue / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008389:Marketing of Health Services / Q000592:standards*; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D009369:Neoplasms / Q000150:complications; D017430:Prostate-Specific Antigen / Q000097:blood; D014481:United States; D014486:United States Food and Drug Administration; D014626:Vaginal Smears / Q000592:standards
chemical_list: D004921:Erythropoietin; D017430:Prostate-Specific Antigen